Reading a hormone panel: what TRT influencers get right and wrong
Quick answer
Hormone panels for TRT monitoring typically include total and free testosterone, estradiol (E2), FSH, LH, prolactin, hematocrit, PSA, and a metabolic panel. Gonadotropin suppression (low FSH/LH) is an expected and clinically significant consequence of exogenous androgen use, reflecting negative feedback on the hypothalamic-pituitary-gonadal axis. Free testosterone is the biologically active fraction, but total testosterone remains a standard marker for dose adequacy and should not be dismissed as irrelevant.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @harveylonsdale_ actually say?
The creator walks viewers through a standard hormone panel, covering FSH, LH, estradiol, total testosterone, free testosterone, and prolactin. The framing is aimed at guys starting TRT or their "first cycle" who receive lab results and have no idea what they mean. Fair enough, that's a real gap. He explains that LH signals testosterone production, FSH triggers androgen-binding protein (ABP) production, and that ABP binding to testosterone creates sperm. He then notes that on exogenous testosterone, FSH and LH will "be in the bin," and that estrogen and prolactin levels depend on individual factors and lifestyle. He correctly separates total from free testosterone, calling total testosterone "kind of pointless" on TRT.
The intent is educational and the delivery is casual. But several of the biological claims underneath the plain-English packaging have real accuracy problems worth unpacking.
Does the science back this up?
Partially. The FSH/LH suppression point is solid. The ABP-sperm claim is where things fall apart, and calling total testosterone "pointless" on TRT is an oversimplification that could mislead people managing their health. The prolactin section is vague to the point of being nearly useless.
On suppression: exogenous testosterone reliably suppresses gonadotropins through negative feedback on the hypothalamic-pituitary axis. This is textbook endocrinology and is well-supported by clinical data, including the landmark hypogonadism trials summarized by Bhasin et al. (2010, New England Journal of Medicine). Expect FSH and LH to drop significantly on TRT. That part is accurate.
On estrogen: the video says levels "depend on how much you aromatize," which is roughly correct. Testosterone converts to estradiol via the enzyme aromatase, with conversion rates varying by body composition, genetics, and dose. Camacho et al. (2013, Journal of Clinical Endocrinology and Metabolism) confirmed that higher adiposity increases aromatase activity, which is why estrogen management is not one-size-fits-all.
What did they get wrong (or right)?
The ABP explanation is where the science goes off track. The creator says FSH stimulates ABP production, that ABP binds testosterone, and that this "creates sperm." This conflates several separate processes. ABP (androgen-binding protein) is produced by Sertoli cells in response to FSH and serves to concentrate androgens locally within the testes to support spermatogenesis. It does not create sperm. Sperm production is a multi-step process requiring FSH, testosterone, and functional Sertoli and Leydig cells. ABP is a facilitator, not a factory. Calling total testosterone "kind of pointless" on TRT is also too strong. While free testosterone is the biologically active fraction, total testosterone remains a useful clinical marker, especially when tracking dose adequacy, conversion rates, and for comparing against population reference ranges. Petak et al. (2002, Endocrine Practice) recommend monitoring both.
What he got right: the free testosterone distinction is genuinely important and under-discussed. The point that prolactin elevation can contribute to erectile dysfunction is supported by clinical literature, including Corona et al. (2012, Journal of Sexual Medicine).
What should you actually know?
If you're reading a hormone panel on TRT, here's what actually matters. FSH and LH dropping toward zero is expected, not alarming. It reflects suppression of the HPG axis. Estradiol monitoring is legitimate but the threshold for concern is individual. The idea that all estrogen is bad is a persistent myth in TRT communities with no serious clinical backing. Symptoms matter more than a single number. Free testosterone is the more functionally relevant metric, but your clinician will still track total testosterone for the full picture. Do not bin that number.
Prolactin elevation can come from several sources: pituitary adenomas, certain medications (antipsychotics, antiemetics), sleep deprivation, and stress. Lifestyle plays a role, but attributing high prolactin purely to "lifestyle choices" without ruling out pathology is premature. Anyone with consistently elevated prolactin should get imaging discussed with their doctor. If you're managing your hormone health on TikTok tutorials alone, that is a problem this video can't solve.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Reading a hormone panel: what TRT influencers get right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Reading a hormone panel: what TRT influencers get right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Hormone panels for TRT monitoring typically include total and free testosterone, estradiol (E2), FSH, LH, prolactin, hematocrit, PSA, and a metabolic panel.
FormBlends verdict
Hormone panels for TRT monitoring typically include total and free testosterone, estradiol (E2), FSH, LH, prolactin, hematocrit, PSA, and a metabolic panel. Gonadotropin suppression (low FSH/LH) is an expected and clinically significant consequence of exogenous androgen use, reflecting negative feedback on the hypothalamic-pituitary-gonadal axis. Free testosterone is the biologically active fraction, but total testosterone remains a standard marker for dose adequacy and should not be dismissed as irrelevant.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Hormone panels for TRT monitoring typically include total and free testosterone, estradiol (E2), FSH, LH, prolactin, hematocrit, PSA, and a metabolic panel. Gonadotropin suppression (low FSH/LH) is an expected and clinically significant consequence of exogenous androgen use, reflecting negative feedback on the hypothalamic-pituitary-gonadal axis. Free testosterone is the biologically active fraction, but total testosterone remains a standard marker for dose adequacy and should not be dismissed as irrelevant.
- FSH and LH suppression is an expected and well-documented consequence of exogenous testosterone use, not a sign something has gone wrong. Bhasin et al. (2010, NEJM) confirm this as a predictable pharmacological effect.
- ABP (androgen-binding protein) concentrates androgens in the testes to support sperm development, but it does not itself produce sperm. The video's explanation of this mechanism is inaccurate.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- FSH and LH suppression is an expected and well-documented consequence of exogenous testosterone use, not a sign something has gone wrong. Bhasin et al. (2010, NEJM) confirm this as a predictable pharmacological effect.
- ABP (androgen-binding protein) concentrates androgens in the testes to support sperm development, but it does not itself produce sperm. The video's explanation of this mechanism is inaccurate.
- Free testosterone is the bioavailable, clinically relevant fraction, but total testosterone is still monitored by clinicians to assess dose response and conversion rates. Dropping it entirely from your panel is not standard practice.
- Aromatase conversion of testosterone to estradiol varies by body composition, dose, and genetics. Higher body fat increases conversion. Estrogen management on TRT should be symptom-guided, not driven by fear of any detectable estradiol.
- Elevated prolactin has multiple causes beyond lifestyle, including pituitary tumors and medications. Anyone with persistently high prolactin should discuss imaging with a doctor before assuming behavioral causes.
- Reading a hormone panel without clinical context is limited. Reference ranges vary by lab, time of day, and testing method. A single number in isolation tells you less than trends over time with a clinician who knows your history.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Modern Man Clinic · TikTok creator
42.7K views on this video
How to Read Your Hormone Panel A lot of dudes send me this captioned as “I have no clue what I’m looking at” I’ve tried to break it down fairly simple, any questions send them over or comment below ❤️👊🏼 #gym #gymrat #fitnessmotivation #gymmotivation #fitness #gymbro #gymlifestyle #fitness #trt #bloodwork
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Modern Man Clinic, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.